Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Obesity × Dalteparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Classical hematology 1

Conditions

Neoplasms 4 Venous Thrombosis 3 Venous Thromboembolism 3 Thrombosis 1 Thromboembolism 1 Pulmonary Embolism 1 Pancreatic Neoplasms 1 Obesity 1 Multiple Myeloma 1 Colorectal Neoplasms 1

Interventions

indole-3-carbinol 1 Vitamin D 1 Observation 1 Nutrition Assessment 1 Methods 1 Metformin 1 Magnesium 1 Educational Status 1 Early Intervention, Educational 1 Docosahexaenoic Acids 1 Dalteparin 1 Cooking 1 Cholecalciferol 1 Blood Specimen Collection 1 Adrenalectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297359 2024-01-23

WAVe

Ottawa Hospital Research Institute

Phase 2 Terminated

Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡